Expand MNOV Menu
MNOV MENU

MNOV Latest Press Releases

-- December 18, 2025 --

MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy Globe Newswire 6:00 AM

-- December 8, 2025 --

MediciNova Announces Update and Basic Characteristic Randomized Patients' of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND Globe Newswire 6:00 AM

-- December 1, 2025 --

Message from the CEO to MediciNova Shareholders Globe Newswire 6:00 PM

-- November 18, 2025 --

MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor Globe Newswire 6:00 AM

-- November 6, 2025 --

MediciNova Wins Contract Research and Development Innovation Award at 2025 BioTech Breakthrough Awards Globe Newswire 6:00 PM

-- November 4, 2025 --

MediciNova Announces Completion of Patient Enrollment in MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast) Globe Newswire 7:00 AM

-- October 30, 2025 --

MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication Globe Newswire 7:00 PM

-- October 6, 2025 --

MediciNova to Present at the LD Micro Main Event XIX Investor Conference Globe Newswire 8:00 AM

-- September 22, 2025 --

MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast) Globe Newswire 8:00 AM

-- September 16, 2025 --

MediciNova Announces Poster Presentation of COMBAT-ALS Clinical Trial at the 36th International Symposium on ALS/MND Globe Newswire 8:00 AM

-- September 8, 2025 --

MediciNova Provides Shareholder Update on Key Developments Globe Newswire 9:00 AM

-- September 3, 2025 --

MediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference Globe Newswire 7:00 AM

-- August 26, 2025 --

MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial Globe Newswire 7:00 PM

-- July 31, 2025 --

MediciNova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million Globe Newswire 7:30 PM

-- July 24, 2025 --

MediciNova provides enrollment update for two key ongoing clinical trials TipRanks 6:28 AM
MEDICINOVA Nears Single-Digit Randomization In Phase?2/3 COMBAT-ALS Trial And Seeks Final Two Patients In Phase?2 Dyslipidemia?And?Fatty?Liver Study Benzinga Newsdesk 6:10 AM
MediciNova Provides Enrollment Update for Ongoing ALS and Hypertriglyceridemia Clinical Trials Globe Newswire 6:00 AM
Market Data Delayed 15 Minutes